Astec LifeSciences Limited has informed the Exchange about General Updates
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec LifeSciences has informed the stock exchanges that it has published newspaper advertisements on 9th July 2025 in Financial Express, Jansatta, and Navshakti, as required under SEBI ICDR Regulation 84(1). The ads confirm completion of dispatch of the Letter of Offer and Application Form for the company's Rights Issue. The issue comprises up to 28,01,673 equity shares of ₹10 face value at ₹890 per share (including ₹880 premium), aggregating up to ₹249.35 crores, in the ratio of 1:7 (1 rights share for every 7 held). Record date was July 4, 2025; the issue opens on July 14, 2025 and closes on July 28, 2025.
This is a routine regulatory disclosure confirming the Rights Issue process is on track. Shareholders on the record date (July 4, 2025) are eligible to apply; the issue is priced at 89 times face value. Shareholders who hold shares in physical form but have not dematerialised them by the record date will not be eligible to apply, so demat-holding shareholders should watch for application forms from the registrar (MUFG Intime).